ICU - SeaStar Medical Holding Corp. Company Value to Earnings Growth Ratio
SeaStar Medical Holding is developing unique systems for the therapy of pediatric kidney inflammation, as confirmed by the estimated PEG ratio on the GURU.Markets chart, where 0.00 represents the latest metric reading. Business prospects depend on FDA certification and the adoption of blood purification methods in clinics. Current scaling is limited by hospital formularies, which is temporarily constraining operating margins.
Metric breakdowns and analytics for SeaStar Medical Holding Corporation (ICU)
- stock value and consensus price forecast:
- market capitalization statistics:
- book capitalization information:
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio SeaStar Medical Holding|ICU - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio SeaStar Medical|ICU - Company Aggregate Debts|Debts to Book Value SeaStar Medical Holding Corp.|ICU - Company Long-Term Debts|Company Short-Term Indebtedness SeaStar Medical|Interim Coverage Ratio seastarmedical.com
- net income and valuation ratios data:
ICU - Net Profit|Future Profit SeaStar Medical Holding|ICU - P/E Multiple|Forward P/E Multiple seastarmedical.com|ICU - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SeaStar Medical Holding Corporation|ICU - Operating profit before deduction of amortization|Earnings per share for the trailing year SeaStar Medical|ICU - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months seastarmedical.com|ICU - Earnings per share growth in current year|Net earnings per one share growth forecast for next year SeaStar Medical Holding
- issuer revenue and sales details:
General company analysis:ICU - SeaStar Medical Holding Corp
To minimize fundamental risks, investors utilize filters that correlate market value with earnings dynamics. The peg_co ratio is calculated by dividing the P/E ratio by the expected business growth rate. For SeaStar Medical Holding (ICU), such a valuation is critical, as synergy with pediatric clinics in the field of cytokine blood purification determines future revenues. A peg_co value below one confirms that the asset is undervalued.
Competing companies
DXCM - Price to Earnings Adjusted for Growth Rate|Penumbra Corp - Price/Earnings to Growth Multiple|PEG Multiple Novanta NOVT|Haemonetics Corp - PEG Multiple|Inspire Medical Systems, Inc. - Company Value to Earnings Growth Ratio|PRCT: PEG Multiple|CNMD - Growth-Adjusted Market Cap to Net Income|PLSE (pulsebiosciences.com) - PEG Multiple|Price/Earnings to Growth Multiple InMode (INMD)|Price/Earnings to Growth Ratio Picard Medical Corp (PMI)|SRDX (Surmodics Inc) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Senseonics Holdings SENS|NPCE - Price/Earnings to Growth Multiple|Tactile Systems Technology Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate Sanuwave Health Inc|OM: PEG Multiple|Growth-Adjusted P/E Ratio ELMD|LNSR (LENSAR Inc) - PEG Multiple|AVITA Medical, Inc (RCEL) - Growth-Adjusted Market Cap to Net Income|PEG Multiple PROF|Price/Earnings to Growth Multiple Baird Medical BDMD|PEG Multiple EDAP (EDAP TMS SA)|PEG Multiple Apyx Medical APYX|ICCM - Price/Earnings to Growth Ratio|LUNG: Price/Earnings to Growth Ratio|TELA (TELA Bio Corp) - Price/Earnings to Growth Multiple|CytoSorbents Corp - Growth-Adjusted Payback Ratio|SRTS (Sensus) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Zynex Medical ZYXI|Price/Earnings to Growth Ratio electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Price to Net Income Growth Ratio|Inspira Technologies Oxy B.H.N. Ltd. - Price/Earnings to Growth Multiple|PEG Multiple IRIDEX Corp. IRIX|Intelligent Bio Solutions Inc - PEG Multiple|Growth-Adjusted Market Cap to Net Income Beyond Air XAIR|Profusa (PFSA) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio SSKN (STRATA Skin)|Price/Earnings to Growth Ratio glucotrack.com|Price/Earnings to Growth Multiple NanoVibronix, Inc. (NAOV)|PEG Multiple VERO|NUWE - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Aethlon Medical AEMD|ASXC: Growth-Adjusted P/E Ratio|AVGR: Price/Earnings to Growth Multiple|BioSig Technologies, Inc. - Company Value to Earnings Growth Ratio|CUTR: PEG Multiple|Growth-Adjusted P/E Ratio KNW|Price/Earnings to Growth Ratio Inari Medical, Inc.|Price to Earnings Adjusted for Growth Rate Nevro Corp. NVRO|Price/Earnings to Growth Ratio ReShape Lifesciences Inc (RSLS)|Price/Earnings to Growth Ratio SILK (silkroadmed.com)
